Posted on November 16, 2026 by Sally-Anne Turner
You’re managing ADHD with medication, and now you’re considering weight loss injections. Perhaps your ADHD medication has affected your appetite over the years, or maybe you’ve struggled with weight management alongside ADHD. Now you’re wondering: can I safely take these medications together? Will they interact? Could combining stimulants with appetite-suppressing weight loss medication cause problems? And how do you ensure you’re eating enough when both medications reduce hunger?
These are important questions that deserve clear, evidence-based answers. The relationship between ADHD medications and weight loss treatments like Wegovy, Mounjaro and Saxenda requires individual assessment. This guide will help you understand the potential interactions, risks and practical strategies for managing both medications safely if treatment is appropriate.
Before we explore how these medications interact, it’s worth understanding what each one does in your body. This helps explain both the concerns and the practical realities of combining them.
ADHD medications fall into two main categories: stimulants and non-stimulants.
Stimulants such as methylphenidate (Ritalin, Concerta) and lisdexamfetamine (Elvanse) influence dopamine and noradrenaline signalling in the brain. These neurotransmitters are involved in attention, activity and impulse control.
A common side effect of stimulant ADHD medication is reduced appetite. You might forget to eat, find food less appealing or notice that you’re less hungry during the day.
However, not everyone experiences appetite suppression, and the effect varies between medications and individuals.
Non-stimulant medications such as atomoxetine and guanfacine work differently. Atomoxetine primarily affects noradrenaline signalling, while guanfacine acts on alpha-2A adrenergic receptors. Both may affect appetite or cause gastrointestinal side effects in some patients.
GLP-1-based weight loss medicines such as Wegovy (semaglutide) and Mounjaro (tirzepatide) act on pathways involved in appetite regulation and glucose control.
Wegovy activates GLP-1 receptors, while Mounjaro activates both GIP and GLP-1 receptors.
These medicines can increase feelings of fullness, reduce hunger and delay gastric emptying.
Clinical trials have demonstrated significant average weight reductions in eligible populations, although results differ between medicines, doses and individuals.
It would be inaccurate to apply a single 15–20% weight-loss figure to everyone taking these treatments.
Like some ADHD medications, GLP-1-based treatments can reduce appetite. This is an important consideration when both medicines are prescribed.
For more context, our guide on weight loss injections and mental health explores related considerations.
ADHD medication and GLP-1-based weight loss treatment may be prescribed together in some circumstances.
However, this does not mean the combination is automatically suitable for everyone.
There is no universal MHRA contraindication that prohibits combining all ADHD medications with Wegovy or Mounjaro.
Nevertheless, potential medication interactions, appetite suppression, gastrointestinal side effects and individual medical risks require assessment.
GLP-1-based medicines delay gastric emptying, which may affect the absorption of some oral medications.
The clinical significance depends on the medicine involved, and it would be inaccurate to guarantee that ADHD medications and weight loss injections cannot interact.
Both ADHD medication and weight loss treatment may affect appetite.
For some people, combining them could make it more difficult to maintain adequate nutritional intake.
Your healthcare provider should review your current medications, medical history and eating patterns before prescribing treatment.
They may also consider blood pressure, heart rate and any relevant gastrointestinal concerns.
The MHRA’s guidance on GLP-1 medicines for weight loss and diabetes explains their licensed uses and important safety considerations.
At Bodyline, treatment suitability should be assessed individually, including consideration of other prescribed medications.
How you respond to this combination will depend on several factors.
Some people taking ADHD medication maintain a normal appetite and may tolerate additional weight-management treatment.
Others already struggle to eat adequately and may find further appetite suppression problematic.
Your particular ADHD medication and dose are relevant, but neither can reliably predict how you will respond to GLP-1 treatment.
Your prescriber should consider your existing side effects and nutritional intake before making a recommendation.
One potential concern when combining these medications is increased appetite suppression.
Understanding this can help you recognise difficulties and discuss appropriate strategies with your healthcare team.
Some people taking appetite-suppressing medications find food less appealing or struggle to recognise hunger.
You might forget meals, eat smaller portions or feel full sooner than expected.
However, severe appetite suppression is not inevitable when combining ADHD medication with GLP-1 treatment.
If reduced appetite makes it difficult to eat adequately, contact your prescriber.
Your body still requires sufficient energy, protein, vitamins and minerals to maintain normal functioning.
The effects of stimulant ADHD medications vary according to the formulation and individual response.
Some people notice that their appetite improves later in the day as their medication’s effects diminish.
Wegovy and Mounjaro are administered weekly, with effects that extend beyond the day of injection.
However, this does not mean appetite suppression remains constant throughout the week or that hunger cannot return between doses.
Your experience may vary, and meal planning should reflect your individual eating patterns.
Inadequate nutrition over time can contribute to fatigue, muscle loss and nutritional deficiencies.
Significant weight loss or restricted food intake may also affect hair health and other aspects of physical wellbeing.
However, these symptoms have several possible causes and should not automatically be attributed to nutritional deficiency.
Maintaining adequate nutrition is particularly important if both medications reduce your appetite.
A healthcare professional or dietitian can help assess whether you’re meeting your nutritional needs.
If you’re taking ADHD medication alongside weight loss injections, practical strategies may help you maintain adequate nutrition.
The most appropriate approach depends on your appetite, treatment response and individual health needs.
When appetite is reduced, regular meal reminders may help.
You could set phone alarms or establish a routine for meals and snacks.
Some people find smaller, more frequent meals easier to manage than larger portions.
However, there is no universal requirement to eat six times daily.
The aim is to maintain adequate nutrition without introducing rigid or stressful eating rules.
If you’re eating smaller portions, choosing a variety of nutritious foods can help support your dietary needs.
Protein is particularly important for maintaining muscle during weight loss.
Options include Greek yoghurt, eggs, nut butters, fish, beans and lean meats.
Fruit, vegetables, wholegrains and healthy fats also contribute important nutrients.
However, no single food is inherently unsuitable, and carbohydrates remain an important part of a balanced diet.
Some people find smoothies, soups or other nutritious drinks easier to consume when appetite is reduced.
These may help supplement food intake where appropriate.
However, liquid nutrition isn’t automatically easier to tolerate, particularly if GLP-1 treatment causes nausea or delayed gastric emptying.
If you’re consistently struggling to eat solid food, seek clinical advice rather than relying on liquid meals alone.
If your ADHD medication affects your appetite, you may find certain times of day easier for eating.
For example, some people prefer breakfast before taking stimulant medication or an evening meal when its effects have diminished.
However, follow the specific instructions for your prescribed ADHD medicine, as some formulations have particular administration requirements.
NICE recommends considering meal timing and nutritional advice when weight loss becomes a concern during ADHD treatment.
The NICE guideline on ADHD diagnosis and management provides further information about medication monitoring and managing weight changes.
Do not alter your ADHD medication schedule or dose without discussing it with your prescriber.
If you’re eating substantially less, your healthcare provider may consider whether you’re at risk of nutritional deficiencies.
Vitamin B12 is important for normal neurological function and red blood cell formation.
Our Vitamin B12 Spray is available as a supplement option.
Vitamin D is also important for normal bone and muscle health. Our Vitamin D3 Spray provides another supplementation option.
However, neither product is required simply because you’re taking ADHD medication or GLP-1 treatment.
They should not be presented as treatments for ADHD symptoms, fatigue or mood changes unless a relevant deficiency or clinical need has been identified.
Discuss supplementation with a healthcare professional if you’re concerned about your nutritional intake.
When taking both medications, it’s important to recognise symptoms that may require clinical review.
Persistent fatigue, dizziness, lightheadedness or difficulty eating adequately should be discussed with your healthcare provider.
These symptoms may have several causes, including dehydration, medication side effects or inadequate nutritional intake.
Hair loss, brittle nails or other physical changes may also warrant assessment.
GLP-1 medicines can cause nausea, vomiting, diarrhoea and constipation.
Persistent vomiting or diarrhoea may lead to dehydration and requires medical advice.
Severe, persistent abdominal pain, particularly if it radiates to the back, requires urgent medical assessment because it may indicate acute pancreatitis.
If you experience changes in concentration, mood or energy levels, discuss them with your clinician.
These symptoms may relate to ADHD, medication effects, nutritional intake, sleep or other health concerns.
It would be inaccurate to assume that irritability or depression during treatment is necessarily caused by inadequate protein or essential fats.
Our article on starting weight loss treatment when you live with depression explores mental health considerations in more detail.
Consistently eating very little or becoming distressed about eating may indicate that additional support is needed.
There is no single calorie threshold, such as 1,000–1,200 calories, that reliably determines nutritional adequacy for every patient.
Your needs depend on factors including body size, age, health and activity levels.
If you begin deliberately restricting food, developing rigid eating rules or feeling anxious about eating, discuss these concerns with your healthcare provider.
A history of eating disorders or current disordered eating behaviours should be considered during treatment assessment.
Beyond appetite concerns, ADHD may create practical challenges when managing weight loss treatment.
ADHD can affect planning, organisation and remembering everyday tasks.
Managing medication schedules, meal preparation and appointments may therefore require additional strategies.
Phone reminders, calendars and simple meal-planning routines may be helpful.
However, injectable medications should always be stored according to their product instructions.
Do not leave injection pens somewhere visible if doing so would expose them to inappropriate temperatures, light or access by children.
For additional practical support, ADHDadultUK is a registered UK charity offering information, resources and peer support for adults living with ADHD.
Some people with ADHD experience impulsive eating or difficulties with food planning.
GLP-1-based medicines may influence appetite and food-related behaviour, but they are not licensed to treat ADHD-related impulsivity.
It would be inaccurate to claim that these medicines reliably reduce impulsive food purchases or other ADHD behaviours.
If impulsive eating is affecting your health, discussing it with a healthcare professional may help identify appropriate strategies.
Some people with ADHD experience difficulties managing emotions.
Food may be used for comfort or stimulation, although this isn’t universal.
If weight loss medication changes your appetite, you may notice changes in your usual eating patterns.
However, it would be inaccurate to assume that GLP-1 treatment removes an emotional coping mechanism or inevitably causes psychological instability.
Where emotional eating is a concern, psychological support may be helpful.
Our guide on food noise explores food-related thoughts and the emerging research into GLP-1 medicines.
Combining ADHD medication with weight loss injections requires appropriate prescribing assessment and communication between healthcare professionals.
Tell your weight-management prescriber which ADHD medications you take, including their doses and any side effects.
This helps them assess potential interactions and nutritional concerns.
Similarly, if you’re already taking weight loss medication and considering starting ADHD treatment, inform the clinician responsible for your ADHD medication.
Do not change either medication independently.
Where appropriate, communication between your ADHD prescriber, GP and weight-management clinician can help support safe treatment.
With your consent, relevant information may be shared about medication changes, side effects and monitoring needs.
Not everyone requires specialist coordination, but it may be helpful where treatment is complex.
Monitoring should reflect your individual medical circumstances.
NICE recommends regular weight monitoring for people taking ADHD medication and assessment of heart rate and blood pressure before and after dose changes and at appropriate intervals.
For adults receiving ADHD medication, NICE recommends measuring weight every six months, with additional assessment where clinically indicated.
However, there is no universal MHRA requirement for people taking both ADHD medication and GLP-1 treatment to attend appointments every two to three weeks.
Your weight-management clinician may recommend additional monitoring based on appetite, nutritional intake, treatment response and side effects.
Food diaries may be useful for some patients, but they should not be required where tracking food could encourage anxiety or disordered eating.
For some people, combining ADHD medication with weight loss injections may not be suitable.
This depends on their health, current medication and potential treatment risks.
If you’re already struggling to eat adequately while taking ADHD medication, further appetite suppression may create additional problems.
Being underweight generally means you would not meet the usual licensed BMI criteria for weight-management medication.
A history of eating disorders also requires careful assessment.
However, a previous eating disorder diagnosis is not automatically a formal MHRA contraindication to every GLP-1 medicine.
Your clinician should consider current symptoms, nutritional health and whether treatment could interfere with recovery.
If you’re taking a stimulant medication that significantly suppresses your appetite, adding GLP-1 treatment may require particular caution.
However, there is no universal dose threshold above which combining ADHD medication with Wegovy or Mounjaro is prohibited.
Your clinician may recommend reviewing your current treatment and nutritional intake before considering additional medication.
Any changes to stimulant treatment should be made by the responsible ADHD prescriber.
If you’ve recently started or changed ADHD medication, your clinician may recommend allowing time to assess its effects before introducing another treatment.
This can help identify side effects and understand how the medication affects your appetite.
However, there is no universal requirement to wait a particular number of months before starting GLP-1 treatment.
The decision should be based on your individual circumstances.
If combining medications isn’t appropriate, other approaches to weight management may be available.
ADHD can affect routines, planning and eating behaviours.
For some people, addressing these difficulties may help support healthier eating patterns.
This could involve reviewing ADHD medication, developing practical organisational strategies or accessing psychological support.
However, optimising ADHD treatment does not necessarily result in weight loss or remove the need for other medical care.
Structured weight-management support may help some people manage their weight without medication.
This could include nutritional guidance, physical activity support and behavioural strategies.
For people with ADHD, practical reminders and simplified routines may make these approaches easier to follow.
Our medical weight loss programmes provide information about available treatment options.
The most appropriate approach depends on your individual health needs.
You don’t necessarily have to make several treatment changes at once.
If your ADHD medication is still being adjusted, it may be appropriate to review its effects before introducing weight-management medication.
Alternatively, if your ADHD is well managed and you meet the relevant prescribing criteria, weight-management treatment may be considered.
There is no universal rule requiring ADHD treatment to be completed or fully stabilised before GLP-1 medication can be prescribed.
If you’re considering combining ADHD medication with weight loss injections, think about how your current medication affects your appetite.
Are you eating adequately? Have you experienced significant weight changes? Do you have any gastrointestinal symptoms or other health concerns?
You may also want to consider whether practical support would help you manage meals, medication schedules and appointments.
Your clinician should assess whether you meet the prescribing criteria for weight-management treatment and review your current medications.
The decision should be based on clinical suitability rather than assumptions about ADHD or stimulant medication.
If you’re uncertain, discuss your concerns with the healthcare professionals responsible for your care.
Taking ADHD medication alongside GLP-1-based weight loss treatment may be appropriate for some people.
However, the combination requires individual assessment, particularly where both medicines affect appetite.
Potential concerns include inadequate nutritional intake, gastrointestinal side effects and possible changes in the absorption of certain oral medicines.
Your healthcare provider should review your medical history, current medications and treatment eligibility before prescribing.
ADHD itself does not automatically exclude you from receiving Wegovy or Mounjaro.
However, neither medicine is licensed to treat ADHD symptoms, and their effects on ADHD-related eating behaviours remain an area requiring further research.
If you’re considering weight loss treatment while taking ADHD medication, speak with a qualified healthcare professional.
They can help determine whether treatment is appropriate and what monitoring or nutritional support may be needed.
At Bodyline Clinic, our team considers relevant medical history and prescribed medications when assessing treatment suitability.
Book a consultation today to discuss your weight-management goals and whether medical treatment may be appropriate for your circumstances.
Our aim is to provide personalised care that considers both your physical health and your existing treatment needs.
BMI calculator
Enter your height and weight to work out your Body Mass Index in seconds.
Your BMI
Find out where you sit and what your options are
Your BMI
Our CQC-regulated clinical team will confirm your eligibility at consultation, in clinic or by video.
CQC regulated 4.8 on Trustpilot
If you'd like advice on your health and wellbeing, our team can talk you through the services we offer.
Explore our servicesWe'd recommend speaking to your GP, who can check everything is OK and offer the right support.
BMI ranges work differently for under 18s. Please speak to your GP for advice.
Please check your height and weight.
Contact us today
Find out more about how we can treat and support you to improve your health and wellbeing.
No-obligation advice from our CQC-regulated team, in clinic or by video.